相似文献
1
What Evidence Is There That Gadobutrol Causes Increasing Signal Intensity within the Dentate Nucleus and Globus Pallidus on Unenhanced T1W MRI in Patients with RRMS?
Eur Radiol. 2016 Mar;26(3):816-7. doi: 10.1007/s00330-015-4019-2. Epub 2015 Sep 21.
2
Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
Eur Radiol. 2016 Mar;26(3):807-15. doi: 10.1007/s00330-015-3879-9. Epub 2015 Jun 25.
3
High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted MR Images: Comparison between Gadobutrol and Linear Gadolinium-Based Contrast Agents.
AJNR Am J Neuroradiol. 2018 Mar;39(3):421-426. doi: 10.3174/ajnr.A5538. Epub 2018 Feb 1.
4
Multiple Administrations of Gadobutrol in the Pediatric Brain: No Change in T1 Signal at MRI.
Radiology. 2018 Oct;289(1):204-209. doi: 10.1148/radiol.2018172988. Epub 2018 Jun 26.
5
High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.
Radiology. 2014 Mar;270(3):834-41. doi: 10.1148/radiol.13131669. Epub 2013 Dec 7.
6
High-Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images: Evaluation of the Macrocyclic Gadolinium-Based Contrast Agent Gadobutrol.
Invest Radiol. 2015 Dec;50(12):805-10. doi: 10.1097/RLI.0000000000000227.
7
Reply to Letter to the Editor re: Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: Correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
Eur Radiol. 2016 Mar;26(3):818-9. doi: 10.1007/s00330-015-4020-9. Epub 2015 Sep 21.
8
Comparison of Unenhanced T1-Weighted Signal Intensities Within the Dentate Nucleus and the Globus Pallidus After Serial Applications of Gadopentetate Dimeglumine Versus Gadobutrol in a Pediatric Population.
Invest Radiol. 2018 Feb;53(2):119-127. doi: 10.1097/RLI.0000000000000419.
9
Signal intensity at unenhanced T1-weighted magnetic resonance in the globus pallidus and dentate nucleus after serial administrations of a macrocyclic gadolinium-based contrast agent in children.
Pediatr Radiol. 2017 Sep;47(10):1345-1352. doi: 10.1007/s00247-017-3874-1. Epub 2017 May 19.
10
Signal intensity change on unenhanced T1-weighted images in dentate nucleus and globus pallidus after multiple administrations of gadoxetate disodium: an intraindividual comparative study.
Eur Radiol. 2017 Oct;27(10):4372-4378. doi: 10.1007/s00330-017-4810-3. Epub 2017 Mar 29.
引用本文的文献
1
Signal Intensity Evaluation in the Dentate Nucleus and Subcortical Gray Matter : Effect of Several Administrations of Gadoterate Meglumine in Multiple Sclerosis.
Clin Neuroradiol. 2022 Sep;32(3):677-685. doi: 10.1007/s00062-021-00995-6. Epub 2021 Feb 25.
2
Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no?
Insights Imaging. 2019 Sep 4;10(1):82. doi: 10.1186/s13244-019-0767-x.
3
[Increased signal intensities and gadolinium levels in the brain after administration of gadolinium-based MR contrast agents : Clinical observations and results from preclinical research].
Radiologe. 2019 Apr;59(4):359-368. doi: 10.1007/s00117-019-0511-z.
4
The biological fate of gadolinium-based MRI contrast agents: a call to action for bioinorganic chemists.
Metallomics. 2019 Feb 20;11(2):240-254. doi: 10.1039/c8mt00302e.
5
Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives.
Front Mol Neurosci. 2018 Sep 20;11:335. doi: 10.3389/fnmol.2018.00335. eCollection 2018.
6
Gadolinium-based contrast agents in children.
Pediatr Radiol. 2018 Aug;48(9):1188-1196. doi: 10.1007/s00247-018-4165-1. Epub 2018 Aug 4.
7
Gadolinium deposition within the paediatric brain: no increased intrinsic T1-weighted signal intensity within the dentate nucleus following the administration of a minimum of four doses of the macrocyclic agent gadobutrol.
Eur Radiol. 2018 Nov;28(11):4882-4889. doi: 10.1007/s00330-018-5464-5. Epub 2018 May 9.
8
Reply to: RE: effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain-a retrospective study in 158 multiple sclerosis (MS) patients.
Radiol Med. 2018 Jul;123(7):535-537. doi: 10.1007/s11547-018-0876-5. Epub 2018 Mar 20.
9
A Review of the Current Evidence on Gadolinium Deposition in the Brain.
Clin Neuroradiol. 2018 Jun;28(2):159-169. doi: 10.1007/s00062-018-0678-0. Epub 2018 Mar 9.
10
Gadolinium Accumulation in the Deep Cerebellar Nuclei and Globus Pallidus After Exposure to Linear but Not Macrocyclic Gadolinium-Based Contrast Agents in a Retrospective Pig Study With High Similarity to Clinical Conditions.
Invest Radiol. 2018 May;53(5):278-285. doi: 10.1097/RLI.0000000000000440.
本文引用的文献
1
Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
Eur Radiol. 2016 Mar;26(3):807-15. doi: 10.1007/s00330-015-3879-9. Epub 2015 Jun 25.
2
Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging.
Radiology. 2015 Jun;275(3):772-82. doi: 10.1148/radiol.15150025. Epub 2015 Mar 5.
3
Multiple sclerosis: hyperintense dentate nucleus on unenhanced T1-weighted MR images is associated with the secondary progressive subtype.
Radiology. 2009 May;251(2):503-10. doi: 10.1148/radiol.2511081269.
4
Iron deposits surrounding multiple sclerosis plaques.
Arch Pathol Lab Med. 1982 Aug;106(8):397-9.
Zotero 插件